Evidence map›Paper›PMID 24513971›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats.

Matthew R Costello, Daisy D Reynaga, Celina Y Mojica, Nurulain T Zaveri, James D Belluzzi, Frances M Leslie

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 78 citations in OpenAlex.

  1. Cigarette Smoke Extract and Nicotine Evoke Similar Interoceptive Effects in a Pavlovian Occasion Setting Task in Male and Female Sprague-Dawley Rats.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  2. Article
  3. Article
  4. The controversial effect of smoking and nicotine in SARS-CoV-2 infection.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Unique, long-term effects of nicotine on adolescent brain.Pharmacology, biochemistry, and behavior · 2020
    Review
  17. Cocaine potently blocks neuronal αActa pharmacologica Sinica · 2020
    Article
  18. Article
  19. Article
  20. Using Product Standards to Render the Most Harmful Tobacco Products Minimally Addictive: Maximum Nicotine Level, Non-Nicotine Constituents, and Scope.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Matthew R CostelloDepartment of Pharmacology, School of Medicine, University of California, Irvine, CA, USA.
Daisy D ReynagaDepartment of Pharmacology, School of Medicine, University of California, Irvine, CA, USA.
Celina Y MojicaDepartment of Pharmacology, School of Medicine, University of California, Irvine, CA, USA.
Nurulain T ZaveriAstraea Therapeutics, Mountain View, CA, USA.
James D BelluzziDepartment of Pharmacology, School of Medicine, University of California, Irvine, CA, USA.
Frances M LeslieDepartment of Pharmacology, School of Medicine, University of California, Irvine, CA, USA.
University of California, Irvine · USAstraea Therapeutics (United States) · US

Funding

PRECLINICAL DEVELOPMENT OF NOVEL SMOKING CESSATION PHARMACOTHERAPIESR44DA033744 · NIDA · ASTRAEA THERAPEUTICS, LLC · PI ZAVERI, NURULAIN T · 2014 to 2016
$1.5M
NIDA NIH HHS R44 DA033744
6 · The paper itself

Abstract

Tobacco dependence is difficult to treat, with the vast majority of those who try to quit relapsing within the first year. Improvements in smoking cessation therapies may be achieved by improving current preclinical research methods. However, most experimental tests in animals use nicotine alone, ignoring the 8000 other constituents found in tobacco smoke. To improve on this model, we have used self-administration to test the reinforcing properties of aqueous cigarette smoke extract (CSE) in rats, made by bubbling cigarette smoke through a saline solution. CSE is more potent than nicotine alone in both the acquisition and maintenance of self-administration, but did not exhibit higher progressive ratio responding. Mecamylamine and varenicline had similar potencies to block nicotine and CSE self-administration, indicating the involvement of nicotinic receptors in CSE reinforcement. Following extinction of responding, reinstatement was triggered by exposing animals to a pharmacological stressor, yohimbine (2.5 mg/kg, i.p.), alone and in combination with cues. Animals that self-administered CSE were significantly more sensitive to stress-induced reinstatement than those that self-administered nicotine. Ligand binding autoradiography studies showed nicotine and CSE to have similar affinities for different nicotinic receptor types. CSE significantly reduced MAO-A and MAO-B activities in vitro, whereas nicotine did not. Although CSE inhibition of MAO-A activity in vitro was found to be partially irreversible, irreversible inhibition was not observed in vivo. These experiments show that CSE is an effective reinforcer acting via nicotinic receptors. Furthermore, it better models MAO inhibition and is more sensitive to stress-induced reinstatement than nicotine alone, which is a potent trigger for relapse in smokers.

Indexed as

Reinforcement, PsychologySmokeAnimalsConditioning, OperantMaleMonoamine OxidaseNicotianaNicotineNicotinic AgonistsRatsRats, Sprague-DawleyReceptors, NicotinicMonoamine OxidaseNicotineNicotinic AgonistsReceptors, NicotinicSmoke

Identifiers

PMID24513971
PMCPMC4059892
OpenAlexW2010492155

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.